MedPath

EFFECTS OF MOBILE PHONE TELE-REMINDER ON IRON STATUS AND DIET QUALITY OF PREGNANT WOMEN AVAILING ANTENATAL CARE AT PHEBE AND CHARLES B. DUNBAR HOSPITALS, BONG COUNTY, MONROVIA-LIBERIAA CLUSTER RANDOMIZED CONTROL TRIA

Not Applicable
Conditions
Nutritional, Metabolic, Endocrine
Pregnancy and Childbirth
Registration Number
PACTR202204658979734
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
150
Inclusion Criteria

In a cluster randomized control trial, the eligibility criteria will be applied to the hospitals
and the individual level of analysis. Hospitals with the highest antenatal care attendance,
equip medical and laboratory facilities and more screening facilities for ANC will be
selected for this study. Phebe and the Charles B. Dunbar hospitals are two centrally referral
hospitals located in Liberia with a high level of ANC attendance. These two hospitals will
be selected because they provide all the minimum recommended ANC services (drugs
availability, laboratory standard, and so on).
At the individual level, pregnant women availing ANC for the first time at the selected
hospitals will be the sample population. Additionally, Pregnant women with no chronic
medical problems, those accessible via mobile phone, and those who are willing to sign the
consent form will be eligible for this study. A total of 147 pregnant women will take part
in this study. Seventy-five (75) pregnant women will be assigned to each treatment arm.

Exclusion Criteria

As exclusion criteria, all pregnant women who have had prior ANC visits, those with
chronic health-related problems in pregnancy, those who are not reachable via mobile
phone, and finally those who will refuse to sign the consent form. Pregnant women who
have had prior ANC visits will be excluded because they have been exposed to other ANC
interventions that could affect the outcome variables

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath